does pfizer have a glp-1 drug Is on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market? Structure Raises $300M as Oral

At minimum, the marketing claims significantly overstate the likely benefits

Compounded vs FDA-Approved GLP-1s This distinction confuses almost everyone

This assumption leads to problems for two reasons

The recommendation is based on a trial comparing semaglutide with placebo in people with overweight/obesity with CVD but no diabetes (Lincoff et al, 2023)

People taking GLP-1 drugs often talk about "food noise" vanishing: the constant mental chatter about food that dominated their days simply goes quiet

Acknowledgements We express our gratitude to the Vice-Chancellor for Research, Isfahan University of Medical Sciences for financial support through the scientific code 398979 and grant number 1989096